Stocks
Arrowhead Pharmaceuticals (ARWR) ROE US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| ROE, % | ? | 27.8% | -18.3% | -34.5% | -166.6% | -75.7% | -163.0% | ||
| Changes by years, y/y, % | +85pp | -46pp | -16pp | -132pp | +91pp | +5.9% | |||
Arrowhead Pharmaceuticals. ROE, %
Arrowhead Pharmaceuticals. ROE, changes, pp
Arrowhead Pharmaceuticals (ARWR) ROE US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| ROE, % | ? | -49.9% | -75.8% | -185.0% | -97.3% | -163.0% | -163.0% | |
| Changes by years, y/y, % | -17pp | +87pp | -145pp | -64pp | -113pp | |||
| Changes by quarters, q/q, % | -16pp | -26pp | -109pp | +88pp | -66pp | |||
